Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 5/20 | 0.46 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.46 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.46 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | GNPAT | O15228 | 1/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
| ▸ | MMP9 | P14780 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27604132 | 0.98 | KMT2A (0.49) | KMT2ACA2CA1FOLH1RIMKLA | |
| SCHEMBL150160 | 0.98 | KMT2A (0.49) | KMT2ACA2CA1FOLH1RIMKLA | |
| SCHEMBL268801 | 0.98 | KMT2A (0.49) | KMT2ACA2CA1FOLH1RIMKLA | |
| SCHEMBL29140272 | 0.96 | KMT2A (0.48) | KMT2ACA2CA1FOLH1RIMKLA | |
| SCHEMBL29140270 | 0.96 | KMT2A (0.48) | KMT2ACA2CA1FOLH1RIMKLA | |
| Water SCHEMBL25386650 | 0.96 | KMT2A (0.48) | KMT2ACA2CA1FOLH1RIMKLA | |
| Magnesium SCHEMBL5524408 | 0.96 | KMT2A (0.48) | KMT2ACA2CA1FOLH1RIMKLA | |
| Water SCHEMBL15765959 | 0.96 | KMT2A (0.48) | KMT2ACA2CA1FOLH1RIMKLA | |
| Glutamine SCHEMBL28063133 | 0.90 | KMT2A (0.61) | KMT2ACA2CA1FOLH1RIMKLA | |
| SCHEMBL29380522 | 0.87 | ECE1 (0.43) | KMT2ACA2CA1FOLH1RIMKLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11534458-B2 | Phosphorus-sparing nutritional composition | ALBION LABORATORIES, INC. (US) | 2022-12-27 | — | — | US | claimed |
| US-20210137975-A1 | PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2021-05-13 | — | — | US | claimed |
| US-10912796-B2 | Phosphorus-sparing nutritional composition | ALBION LABORATORIES, INC. (US) | 2021-02-09 | — | — | US | claimed |
| US-20180280430-A1 | COMPOSITION FOR IMPROVED PERFORMANCE | BALCHEM CORPORATION | 2018-10-04 | — | — | US | claimed |
| EP-3355989-A1 | COMPOSITION FOR IMPROVED PERFORMANCE | Balchem Corporation (US) | 2018-08-08 | — | — | EP | claimed |
| US-20160015746-A1 | PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2016-01-21 | — | — | US | claimed |
| EP-2967117-A1 | PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION | AMIP, LLC (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014159886-A1 | PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION | AMIP, LLC (US) | 2014-10-02 | — | — | WO | claimed |
| US-8840937-B2 | Composition and method for recovery from mild traumatic brain injury | FORD JR WALTER JOE (US) | 2014-09-23 | — | — | US | claimed |
| US-20130224169-A1 | COMPOSITION AND METHOD FOR RECOVERY FROM MILD TRAUMATIC BRAIN INJURY | FORD JR WALTER JOE (US) | 2013-08-29 | — | — | US | claimed |
| US-20240115590-A1 | COMPOSITIONS AND THERAPEUTIC METHODS FOR TREATING CHRONIC SEQUALAE FOLLOWING VIRAL INFECTIONS | SCHOCH JEAN JACQUES (US) | 2024-04-11 | — | — | US | disclosed |
| US-11534458-B2 | Phosphorus-sparing nutritional composition | ALBION LABORATORIES, INC. (US) | 2022-12-27 | — | — | US | disclosed |
| US-20220233476-A1 | IRON SUPPLEMENT | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2022-07-28 | — | — | US | disclosed |
| US-20220160830-A1 | COMPOSITIONS COMPRISING CHOLINE | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2022-05-26 | — | — | US | disclosed |
| US-11331287-B2 | Iron supplement | BALCHEM CORPORATION (US) | 2022-05-17 | — | — | US | disclosed |
| WO-2014197250-A1 | IRON SUPPLEMENT | AMIP, LLC (US) | 2014-12-11 | — | — | WO | disclosed |
| WO-2014159886-A1 | PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION | AMIP, LLC (US) | 2014-10-02 | — | — | WO | disclosed |
| US-8840937-B2 | Composition and method for recovery from mild traumatic brain injury | FORD JR WALTER JOE (US) | 2014-09-23 | — | — | US | disclosed |
| US-20130224169-A1 | COMPOSITION AND METHOD FOR RECOVERY FROM MILD TRAUMATIC BRAIN INJURY | FORD JR WALTER JOE (US) | 2013-08-29 | — | — | US | disclosed |
| US-20070196496-A1 | Delivery systems for functional ingredients | FARBER MICHAEL | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11534458-B2 | Phosphorus-sparing nutritional composition | PHPT1, PPA1, PTH1R | KMT2A 2882/4885CA2 72/4885CA1 324/4885 |
| US-20210137975-A1 | PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION | PHPT1, PPA1, PTH1R | KMT2A 2882/4885CA2 72/4885CA1 324/4885 |
| US-20160015746-A1 | PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION | PHPT1, PPA1, PTH1R | KMT2A 2882/4885CA2 72/4885CA1 324/4885 |
| US-10912796-B2 | Phosphorus-sparing nutritional composition | PHPT1, PPA1, PTH1R | KMT2A 2882/4885CA2 72/4885CA1 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.